» Articles » PMID: 27589845

Hypoxia-responsive MiR-210 Promotes Self-renewal Capacity of Colon Tumor-initiating Cells by Repressing ISCU and by Inducing Lactate Production

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Sep 3
PMID 27589845
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Low oxygen concentrations (hypoxia) are known to affect the cellular metabolism and have been suggested to regulate a subpopulation of cancer cells with tumorigenic properties, the so-called tumor-initiating cells (TICs). To better understand the mechanism of hypoxia-induced TIC activation, we set out to study the role of hypoxia-responsive miRNAs in recently established colon cancer patient-derived TICs. We were able to show that low oxygen concentrations consistently lead to the upregulation of miR-210 in different primary TIC-enriched cultures. Both stable overexpression of miR-210 and knockdown of its target gene ISCU resulted in enhanced TIC self-renewal. We could validate the tumorigenic properties of miR- 210 in in vivo experiments by showing that ectopic expression of miR-210 results in increased tumor incidence. Furthermore, enhanced miR-210 expression correlated with reduced TCA cycle activity and increased lactate levels. Importantly, by blocking lactate production via inhibition of LDHA, we could reverse the promoting effect of miR-210 on self-renewal capacity, thereby emphasizing the regulatory impact of the glycolytic phenotype on colon TIC properties. Finally, by assessing expression levels in patient tissue, we could demonstrate the clinical relevance of the miR-210/ISCU signaling axis for colorectal carcinoma. Taken together, our study highlights the importance of hypoxia-induced miR-210 in the regulation of colon cancer initiation.

Citing Articles

Hemoglobin levels in red blood cells and risk of colorectal cancer: A causal investigation based on Mendelian randomization.

Shen J, Qin X, Zeng X, Xiao H, Lai S Medicine (Baltimore). 2024; 103(48):e40562.

PMID: 39612383 PMC: 11608680. DOI: 10.1097/MD.0000000000040562.


Metabolite and protein shifts in mature erythrocyte under hypoxia.

Jin X, Zhang Y, Wang D, Zhang X, Li Y, Wang D iScience. 2024; 27(4):109315.

PMID: 38487547 PMC: 10937114. DOI: 10.1016/j.isci.2024.109315.


P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.

Zhang J, Li C, Sun L, Sun D, Zhao T Oncol Rep. 2023; 50(6).

PMID: 37921068 PMC: 10636723. DOI: 10.3892/or.2023.8656.


Hypoxia and hypoxia-inducible factors in Kaposi sarcoma-associated herpesvirus infection and disease pathogenesis.

Davis D, Shrestha P, Yarchoan R J Med Virol. 2023; 95(9):e29071.

PMID: 37665216 PMC: 10502919. DOI: 10.1002/jmv.29071.


Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.

Mondal D, Shinde S, Paul S, Thakur S, Velu G, Tiwari A Front Oncol. 2023; 13:1230273.

PMID: 37637043 PMC: 10448964. DOI: 10.3389/fonc.2023.1230273.


References
1.
Verzi M, Shin H, Ho L, Liu X, Shivdasani R . Essential and redundant functions of caudal family proteins in activating adult intestinal genes. Mol Cell Biol. 2011; 31(10):2026-39. PMC: 3133364. DOI: 10.1128/MCB.01250-10. View

2.
Haan C, Behrmann I . A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. J Immunol Methods. 2006; 318(1-2):11-9. DOI: 10.1016/j.jim.2006.07.027. View

3.
Daniele S, Giacomelli C, Zappelli E, Granchi C, Trincavelli M, Minutolo F . Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death. Sci Rep. 2015; 5:15556. PMC: 4616042. DOI: 10.1038/srep15556. View

4.
Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6):501-13. PMC: 2693960. DOI: 10.1016/j.ccr.2009.03.018. View

5.
Heddleston J, Li Z, McLendon R, Hjelmeland A, Rich J . The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 2009; 8(20):3274-84. PMC: 2825672. DOI: 10.4161/cc.8.20.9701. View